ISWH
International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) continues to position itself in a strong role in several high-growth markets. We would view this as a deep value opportunity for a few reasons, with each built of the same DNA in terms of market reasoning.
Besado Growth: First, the company produces an award-winning top-shelf tequila (“Besado”) that has seen a clear uptick in sales this quarter and has a strong seasonal tailwind for Q4, suggesting that the segment will contribute an outsized performance when the company comes to putting out its audited 10K for 2019 in a few weeks. That’s likely to surprise the skeptics and justify higher prices for shares.
Home Healthcare Growth: Second, ISWH is an emerging leader in the home healthcare space, with operations that have been rapidly expanding, including quadruple digit sales growth over the past six months, and projections for and expanded client base and headcount to service that growing list of clients along the way.
CBD Growth: Third, the main source of growth for ISWH is likely to be its potent CBD products segment, which is positioned for accelerating growth in 2020 following its landmark partnership with BioPulse Labs, a nationally-recognized brand development and manufacturing leader in the nano-infusion of CBD products, which is possibly the fastest growing major consumer market on the planet right now.
Right now, the chart would seem to agree with this analysis in terms of a loss of downside momentum. But the price remains at absolute bargain basement levels.
International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) continues to position itself in a strong role in several high-growth markets. We would view this as a deep value opportunity for a few reasons, with each built of the same DNA in terms of market reasoning.
Besado Growth: First, the company produces an award-winning top-shelf tequila (“Besado”) that has seen a clear uptick in sales this quarter and has a strong seasonal tailwind for Q4, suggesting that the segment will contribute an outsized performance when the company comes to putting out its audited 10K for 2019 in a few weeks. That’s likely to surprise the skeptics and justify higher prices for shares.
Home Healthcare Growth: Second, ISWH is an emerging leader in the home healthcare space, with operations that have been rapidly expanding, including quadruple digit sales growth over the past six months, and projections for and expanded client base and headcount to service that growing list of clients along the way.
CBD Growth: Third, the main source of growth for ISWH is likely to be its potent CBD products segment, which is positioned for accelerating growth in 2020 following its landmark partnership with BioPulse Labs, a nationally-recognized brand development and manufacturing leader in the nano-infusion of CBD products, which is possibly the fastest growing major consumer market on the planet right now.
Right now, the chart would seem to agree with this analysis in terms of a loss of downside momentum. But the price remains at absolute bargain basement levels.